Open AccessAssessment of the feed additive consisting of Lentilactobacillus buchneri (formerly Lactobacillus buchneri ) DSM 16774 for all animal species for the renewal of its authorisation (Lactosan GmbH & Co. KG )
Author(s) -
Bampidis Vasileios,
Azimonti Giovanna,
Bastos Maria de Lourdes,
Christensen Henrik,
Dusemund Birgit,
Fašmon Durjava Mojca,
Kouba Maryline,
LópezAlonso Marta,
López Puente Secundino,
Marcon Francesca,
Mayo Baltasar,
Pechová Alena,
Petkova Mariana,
Ramos Fernando,
Sanz Yolanda,
Villa Roberto Edoardo,
Woutersen Ruud,
Saarela Maria,
Brozzi Rosella,
Galobart Jaume,
Revez Joana,
Gregoretti Lucilla
Publication year - 2021
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2021.6696
Subject(s) - lactobacillus buchneri , authorization , context (archaeology) , european commission , microbiology and biotechnology , feed additive , animal feed , biology , toxicology , european union , food science , business , lactic acid , computer science , computer security , paleontology , genetics , broiler , bacteria , economic policy , lactobacillus plantarum
Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed ( FEEDAP ) was asked to deliver a scientific opinion on the assessment of the application for renewal of authorisation of Lentilactobacillus buchneri (formerly Lactobacillus buchneri ) DSM 16774 as a technological additive to improve ensiling of forage for all animal species. The applicant has provided evidence that the additive currently on the market complies with the existing conditions of authorisation. There is no evidence that would lead the FEEDAP Panel to reconsider its previous conclusions. Thus, the Panel concludes that the additive remains safe for all animal species, consumer and the environment under the authorised conditions of use. Regarding user safety Lentilactobacillus buchneri DSM 16774 is not irritant to skin and eyes but is considered a skin and respiratory sensitiser. There is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.